CAPTEA Safety Questions, CAPTEA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CAPTEA. Our extensive database of CAPTEA adverse events and CAPTEA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CAPTEA
CAPTEA Safety Reports
Total CAPTEA reports: 5.CAPTEA FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 2.
Take CAPTEA Side Effects Survey or Share Your CAPTEA Story. Read More Here.
Health Professional from FRANCE reported CAPTEA problem on July 03, 2006. Female patient, 93 years of age, was diagnosed with essential hypertension, urinary incontinence and was treated with CAPTEA. After drug was administered, patient experienced the following problems/side effects: dysarthria, hypotension, incorrect dose administered, transient ischaemic attack. CAPTEA dosage: unknown. During the same period patient was treated with LAMALINE, ACTONEL, CACIT D, OXYBUTYNIN, KALEORID. Patient was hospitalized. Patient recovered.
CAPTEA problem was reported by a Health Professional from FRANCE on Sept 14, 2006. Male patient, 56 years of age, was treated with CAPTEA. After drug was administered, patient experienced the following problems/side effects: dysphagia, oesophagitis. CAPTEA dosage: unknown. During the same period patient was treated with PLAVIX, CAPTOPRIL, KALEORID. Patient recovered.
Health Professional from FRANCE reported CAPTEA problem on Oct 16, 2006. Male patient, 73 years of age, was treated with CAPTEA. After drug was administered, patient experienced the following problems/side effects: hepatitis, jaundice, renal failure acute. CAPTEA dosage: unknown. During the same period patient was treated with GLUCOPHAGE, NEXEN. Patient died on 09/27/2006.
CAPTEA problem was reported by a Health Professional from FRANCE on Oct 16, 2006. Male patient, 73 years of age, was treated with CAPTEA. After drug was administered, patient experienced the following problems/side effects: hepatitis, jaundice, renal failure acute. CAPTEA dosage: unknown. During the same period patient was treated with GLUCOPHAGE, NEXEN. Patient died on 09/27/2006.
Physician from FRANCE reported CAPTEA problem on Oct 17, 2006. Male patient, 70 years of age, was diagnosed with nail tinea and was treated with CAPTEA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatitis cholestatic. CAPTEA dosage: unknown. During the same period patient was treated with SIMVASTATIN, TADENAN, LAMISIL. Patient was hospitalized. Patient recovered.